Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 16

Showing 16 citing articles:

Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
Linxiang Zhang, Xueying Zhang, Yanbin Shi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
Understanding the Toxicity Profile of Approved ADCs
P Martínez, Alfonso López de Sá, Cristina Díaz‐Tejeiro, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 258-258
Open Access
Histone modification inhibitors: An emerging frontier in thyroid Cancer therapy
Qi Wang, Shu Sun, Guojun Sun, et al.
Cellular Signalling (2025), pp. 111703-111703
Closed Access
Epithelial-mesenchymal Transition Promotes Metabolic Reprogramming to Suppress Ferroptosis
Wenzheng Guo, Zhibing Duan, Jingjing Wu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Synthesis and DNA binding studies of novel triazine-isatin hybrids: experimental and computational insights
Alia Mushtaq, Muhammad Moazzam Naseer
RSC Advances (2025) Vol. 15, Iss. 11, pp. 8443-8455
Open Access
G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications
Yuchao Ni, Mingchen Shi, Liangliang Liu, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2175-2175
Open Access | Times Cited: 3
Dual-target EZH2 inhibitor: latest advances in medicinal chemistry
Wei Lai, Dan Mei, Sijia Hu, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 15, pp. 1561-1582
Closed Access | Times Cited: 2
Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer
Yaxun Guo, Yuzhan Li, Zhongmei Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer
Chaohua Liu, Jiana Li, Fei Xu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Epigallocatechin-3-gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer bothin vitroandin vivo
Kirankumar Nalla, Biji Chatterjee, Jagadeesha Poyya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications
Xiaohong Duan, Zhiyao Xing, Lu Qiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Theoretical investigations on modeling blood flow through vessel for understanding effectiveness of magnetic nanocarrier drug delivery systems
Rami M. Alzhrani, Mohammed F. Aldawsari, Jawaher Abdullah Alamoudi
Frontiers in Medicine (2024) Vol. 11
Open Access
Covalent inhibitors meet epigenetics: new opportunities
Qiang Feng, Luoting Yu, Li Lu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116951-116951
Closed Access
Epigallocatechin gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer both in vitro and in vivo
Kirankumar Nalla, Biji Chatterjee, Jagadeesha Poyya, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 763, pp. 110223-110223
Closed Access
Page 1

Scroll to top